Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-08-21

FDA Approved: DIGOXIN — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Digoxin submitted by Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DIGOXIN (Digoxin)

Snippet

SUPPL AP for DIGOXIN (DIGOXIN)